Local ablation with continued TKI treatment can be used as a treatment strategy for advanced‐stage NSCLC in which extracentral nervous system oligoprogressive disease has developed during EGFR TKI treatment.33 The gene discussed is EGFR; the disease is non-small cell lung carcinoma.